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Platelet activation and aggregation play a promi-
nent role in the initial response of the vessel wall to
mechanical injury. It has been suggested that platelet
activation and aggregation at regions of intima or
medial injury mediate intimal hyperplasia (IH) and
eventual lumen stenosis after vascular reconstruction
or angioplasty.1-3 A major feature of the response to
this injury is an increase in the number of vascular
smooth muscle cells (VSMCs) in the intima.4
Platelets adhere to sites of injury, undergo morpho-
logical transformation, release granular contents
such as adenosine diphosphate (ADP) and throm-
boxane (TX) A2, and express a receptor, glycopro-
tein IIb/IIIa, that is essential for fibrinogen cross-
linking, platelet aggregation, and thrombus forma-
tion.5 These processes also result in the release of
chemotactic and mitogenic growth factors, includ-
ing platelet-derived growth factor (PDGF), trans-
forming growth factor- b , and basic fibroblast
growth factor, which induce VSMC proliferation
and migration after vascular injury.6-8 Recent studies
have indicated that antibodies to fibrinogen glyco-
protein IIb/IIIa receptor may offer complete inhi-
bition of platelet function and help abrogate the ini-
tial “response to injury” process.9-11 
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Purpose: Vascular smooth muscle cell (VSMC) proliferation and migration to the subin-
tima or intimal hyperplasia (IH) occur after arterial injury and are thought to be
induced by mitogenic factors released from activated platelets. Because low flow (LF)
and shear have been attributed to the localization and progression of IH, we postulated
that hemodynamic factors may regulate the degree of platelet activation, as measured by
plasma thromboxane B2 (TXB2) and platelet-derived growth factor-AB (PDGF-AB)
release at regions of experimental arterial injury.
Methods: The right common carotid artery (CCA) was subjected to balloon injury in 18
New Zealand White male rabbits. Flow in the injured CCA was reduced by out-flow li-
gation (LF group, n = 6) or increased by ligation of the left CCA (high flow [HF]
group, n = 6). In six other animals, flow was preserved (normal flow [NF] group). Mean
blood flow and pressure in the right CCA were measured thereafter at 10 and 30 min-
utes. Plasma TXB2 and PDGF-AB levels were determined with the enzyme-linked
immunosorbent assay method in each animal with blood samples taken systematically
before injury (baseline) and in the distal CCA at similar time points.
Results: At 10 minutes, mean blood flow was reduced from 20 ± 2 ml/min in the NF
group to 7 ± 1 ml/min in the LF group animals (p < 0.01) and increased to 32 ± 2
ml/min in the HF group animals (p < 0.05). Mean arterial blood pressure did not dif-
fer among the groups. Hemodynamic parameters were similar at 10 and 30 minutes.
TXB2 levels were more than fourfold greater in the LF group than in the HF and NF
groups at both time points (p < 0.05). In addition, there was a twofold increase in plas-
ma PDGF-AB level at 10 minutes in the LF group compared with baseline levels 
(p < 0.05). 
Conclusion: Platelet activation at regions of acute vascular injury was determined to be
flow dependent. Upregulated platelet activity in low flow conditions may be due to
increased platelet exposure time to subendothelial collagen and is greatly attenuated if
normal or increased flow is present. (J Vasc Surg 1998;27:910-8.)
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Hemodynamic factors (i.e., flow and shear
stress) may modulate platelet activity and throm-
bosis formation either directly12,13 or indirectly by
regulating the mechanism controlling endothelial
coagulation. For example, shear stress induces sig-
nificant increases in levels of prostacyclin, tissue
plasminogen activator, and thrombomodulin
receptor messenger RNA.14-18 Evidence also has
accrued that low flow (LF) and shear stress are
associated with the localization and progression of
IH.19-21 We previously studied how hemodynamic
factors modulate key molecular events that influ-
ence matrix degradation and VSMC cell migration
to the subintima and IH.22 In the current study, we
examined the role of blood flow in regulating the
degree of platelet activation after experimental
arterial injury.
We measured acute plasma levels of TXB2, a sta-
ble metabolite of TXA2 that is released from activat-
ed platelets, and of PDGF-AB, a mitogenic factor
that is released after platelet aggregation in relation
to different flow conditions subsequent to balloon
injury of the rabbit carotid artery.
MATERIALS AND METHODS
Animal model. Adult New Zealand White male
rabbits, weighing 3.0 to 3.5 kg and fed normal rab-
bit chow (n = 18), were used for the study. Anes-
thesia was induced with intramuscular ketamine
hydrochloride (40 mg/kg) and xylazine (5 mg/kg)
and maintained with 1% halothane via endotracheal
intubation. A 2F balloon catheter was introduced
twice via the facial branch of the right common
carotid artery (CCA) for 10 cm to induce mural
endothelial denudation and the usually associated
subjacent medial injury of the entire length of the
right CCA. The balloon was consistently inflated
with 0.2 ml of normal saline. Housing and handling
of animal were in compliance with “Principles of
Laboratory Animal Care” and “Guide for the Care
and Use of Laboratory Animals” (NIH Publication
No. 80-23, revised 1985).
Flow modulation and hemodynamic measure-
ments. Blood flow in the right CCA was reduced
through ligation of three of the four terminal CCA
branches (LF group, n = 6) or increased through li-
gation of the contralateral left CCA (high flow [HF]
group, n = 6) as described by Langille et al.23 In six
other animals, no hemodynamic manipulation was
undertaken, and flow was preserved (normal flow
[NF] group). Mean blood flow was measured with
the use of transit time ultrasonography (Transonics,
Ithaca, N.Y.) in the right CCA before and after flow
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 5 Bassiouny et al. 911
modulation. Mean arterial pressure was monitored
and recorded with an indwelling transduced 23-
gauge catheter in the facial artery. Flow and blood
pressure measurements were obtained after denuda-
tion injury (baseline), at 10 and 30 minutes after
blood flow manipulation.
Measurement of plasma TXB2. Blood was
drawn from the central artery of the ear before oper-
ation (baseline) and from the right facial artery distal
to the injured CCA via a catheter at 10 and 30 min-
utes after blood flow modulation. Blood was cen-
trifuged immediately at 800 g for 20 minutes. Platelet-
rich plasma was collected and stored at –20° C until
the assay was performed. 
Plasma TXB2 was measured with an enzyme
immunoassay kit24 (Cayman Chemical, Ann Arbor,
Mich.). Before the plasma was added to the assay
well, it (0.25 ml) was purified through a C-18
reverse phase Sep-Pak cartridge (Millipore, Mil-
ford, Mass.) after the removal of precipitated pro-
teins. The cartridge was rinsed with 5 ml of Ultra-
Pure water, followed by hexane, and then eluted
with 5 ml of ethyl acetate containing 1% methanol.
After evaporation under a stream of dry nitrogen,
the dry samples were dissolved in 0.5 ml of assay
buffer (100 mmol/L K2HPO4, pH 7.4, 1.5
mmol/L NaN3, 0.4 mol/L NaCl, 1 mol/L EDTA,
and 0.1% bovine serum albumin). We added 50 m l
of samples or standard to the wells of the plate,
which had been coated with mouse monoclonal
antibody, followed by 50 m l of acetylcholinesterase
linked to TXB2 and 50 m l of TXB2-specific rabbit
antiserum. The plate was then incubated for 18
hours at room temperature. After washing, the
plate was developed with 200 m l of Ellman’s
reagent, a substrate to acetylcholinesterase that
consists of acetylthiocholine and 5,5´-dithio-bis(2-
nitrobenzoic acid). Absorbance was determined
with an enzyme-linked immunosorbent assay
(ELISA) reader (Spectra Max 340, Molecular
Devices, Menlo Park, Calif.) at 412 nm. The con-
centration of TXB2 in each sample was calculated
by identifying the percentage of bound sample
divided by the percentage of maximum bound
sample on the standard curve.
Determination of plasma PDGF-AB levels.
Plasma was obtained as described above. PDGF-
AB levels were detected with a solid-phase ELISA
technique25 (Quantikine immunoassay kit, R&D
Systems, Minneapolis, Minn.). Of each sample or
standard, 100 m l was loaded onto the wells of the
plate, which had been coated with a murine mon-
oclonal antibody specific for human PDGF-AA.
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After incubation for 2 hours at room temperature,
the plate was washed and incubated with a horse-
radish peroxidase-linked polyclonal antibody spe-
cific for human PDGF-BB for an additional 2
hours at room temperature. After washing, 100 m l
of substrate solution (tetramethylbenzidine) was
added to each well. The absorbance of the immun-
oreaction was read on a Kinetic microplate reader
(Molecular Devices) at 450 nm. The concentration
of PDGF-AB in each sample was calculated based
on the standard curve, which was plotted on
log/log paper. 
Data analysis. Analysis of variance (ANOVA)
was used to compare the mean responses in the
three groups defined by animals assigned to the tar-
geted LF, NF, and HF rates (these were performed
on both the original and log-transformed scales; the
latter scale was used to stabilize the variance across
groups). The relationship between mean flow and
TXB2 values was calculated with Spearman’s rank-
order correlation coefficients. Results were expres-
sed as mean value ± SEM. A value of p < 0.05 was
considered to be significant.
RESULTS
Hemodynamic parameters. Mean baseline
blood flow did not differ among groups: 22 ± 1
ml/min, 19 ± 2 ml/min, and 21 ± 1 ml/min in the
NF, LF, and HF groups respectively. At 10 minutes,
out-flow ligation was successful in reducing flow by
threefold to 7 ± 1 ml/min in the LF group (p <
0.01), whereas ligation of the contralateral left CCA
increased baseline flow by 1.5-fold to 32 ± 2
ml/min in the HF group (p < 0.05) compared with
the NF group (20 ± 2 ml/min). At 30 minutes, flow
rates in the different groups were similar to those
measured at 10 minutes (Fig. 1). Mean arterial pres-
sure (MAP) in the right CCA did not differ among
the LF, HF, and NF groups at all time points and
ranged from 49 mm Hg to 56 mm Hg.
Plasma TXB2 levels under different flow con-
ditions. Systemic TXB2 levels before injury (base-
line) ranged from 0.5 to 0.7 ng/ml. After blood
flow modulation, there was a greater than fourfold
increase in TXB2 levels in the LF group at 10 and 30
minutes (3.6 ± 0.9 ng/ml and 3.8 ± 1.4 ng/ml,
respectively) compared with the NF (0.8 ± 0.3
Fig. 1. Blood flow measurement in the three experimental groups. Blood flow was markedly
reduced in the LF group and significantly increased in the HF group compared with the NF
group at 10 and 30 minutes after flow modulation. There were no differences among flow
rates in the different groups before flow modulation (baseline). 
Data are presented as mean ± SEM. 
*p < 0.05 compared with the NF group.
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ng/ml and 1 ± 0.4 ng/ml) and HF (0.7 ± 0.2
ng/ml and 0.8 ± 0.1 ng/ml) groups (p < 0.05) at
similar time points. TXB2 levels in the NF and HF
groups were not significantly different from baseline
values (Fig. 2). Spearman’s rank-order correlation
coefficients are significant between TXB2 levels and
mean flow at 10 minutes (r = 0.51, p = 0.029) and
30 minutes (r = 0.58, p = 0.012). There is clustering
of the low and high values (Fig. 3). The plots con-
sistently show an increase in TXB2 levels when LF
conditions prevail. 
This is further substantiated by ANOVA of the
log-transformed scales and standard deviation values
of the LF, NF, and HF groups. At 10 minutes, the
null hypothesis that all three groups have the same
mean can be rejected (F = 6.16, p = 0.011). The
pairwise comparisons indicate that the differences
between the LF and NF groups and the LF and HF
groups are significant (p < 0.05) but that the differ-
ence between the NF and HF groups is not (p =
NS). At 30 minutes, although the F test value from
the ANOVA is significant (F = 3.83, p = 0.045), the
pairwise group differences are not significant after
Tukey’s allowance for multiple comparisons. 
Plasma PDGF-AB levels under different flow
conditions. Systemic plasma PDGF-AB (baseline)
ranged from 31 to 36 pg/ml. At 10 minutes, there
was close to a twofold increase in PDGF-AB levels in
LF group compared with control values (57.6 ± 6.3
pg/ml vs 34 ± 4.6 pg/ml, p < 0.05). At 30 minutes,
PDGF-AB levels declined to values close to baseline
(39.5 ± 6.2 vs 34 ± 4.6 pg/ml, p = NS). A similar
trend was found in the NF group, but this was not
significantly different from control values (44 ± 4.4
vs 36 ± 2.3 ng/ml, p = NS). PDGF-AB levels did
not differ in the HF group from control values at
either the 10 or 30 minute time point (35 ± 1.8 and
24.8 ± 4.9 ng/ml vs 31 ± 2.2 ng/ml, respectively, 
p = NS) (Fig. 4).
DISCUSSION
Deendothelialization and medial injury results in
the immediate adhesion of platelets to interstitial
collagen in the injured vessel wall. The attached
platelet releases ADP and activates the arachidonic
acid synthesis pathway to produce TXA2, a potent
chemoattractant and smooth muscle cell mitogen,
leading to additional platelet recruitment and
Fig. 2. Plasma TXB2 levels in the three experimental groups. There was a greater than four-
fold increase in TXB2 levels in the LF group at 10 and 30 minutes after blood flow modula-
tion compared with the NF and HF groups. TXB2 levels were minimally increased in the NF
and HF groups compared with baseline levels. Data are presented as mean ± SEM. 
*p < 0.05 compared with the NF and HF groups.
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platelet aggregation.5 Because TXA2 released from
activated platelet is unstable and is rapidly metabo-
lized, its stable metabolite TXB2 has been used as a
measure of platelet activation.26 The findings of this
study indicate that platelet activation at regions of
experimental arterial injury is flow dependant. In
addition, upregulated platelet activity under LF con-
ditions was accompanied by acute increases in plas-
ma PDGF-AB levels.
Hemodynamic shear forces have been shown to
exert both direct and indirect effects on platelet
activity. In vitro, normal platelets fail to aggregate
when placed in an aggregometer (low shear envi-
ronment) unless an agonist such as collagen or ADP
is added. However, platelets exposed to shear stress
levels of 60 to 80 dynes/cm in a cone-and-plate vis-
cometer (high shear environment) aggregate with-
out the addition of an exogenous agonist.27 A num-
ber of mechanisms by which shear forces induce
platelet aggregation have been elucidated. High
shear stress induces a conformational change in the
platelet membrane and thereby increases its affinity
Fig. 3. The individual flow levels and TXB2 levels were plotted. The plots consistently show
an increase in TXB2 levels when LF conditions prevail.
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to von Willebrand’s factor on glycoprotein IIb/IIIa
and increases adhesion to the subendothelium.28
Shear forces have also been reported to increase
cytosolic free Ca2+ concentration, and the dense
granule release by which shear forces activate
platelets is unknown but may be related to a shear-
sensitive Ca2+ channel.29
Mazeaud et al.30 investigated platelet aggregation
in relation to in vivo shear forces in hypertensive
patients and found that ex vivo platelet reactivity to
ADP or collagen was inversely related to the in vivo
brachial artery blood flow velocity, wall shear rate,
and stress. It has been shown that shear stress may
indirectly regulate platelet activity by stimulating the
production of endothelium and smooth muscle-
derived antiaggregatory agents, such as prostacy-
clin,15,31 endothelium-derived relaxing factor,32 and
nitric oxide.33 Shear also increases the synthesis of tis-
sue plasminogen activator17 and plasmin,which
cleaves the platelet glycoprotein lb receptor and thus
attenuates platelet activation and its aggregation to
the injured vessel wall.34 Thus, platelet function and
aggregation in response to hemodynamic shear are
governed by a dynamic equilibrium between its
direct effects on platelet activation and its indirect
role in enhancing the production of antiaggregatory
agents from the vessel wall.
The role of flow in regulating platelet activity in
vivo after arterial injury has been previously studied
in stenoses. Merino et al35 demonstrated that under
critical local high shear rate conditions, platelet
deposition was enhanced, although the hemody-
namic parameters differed from those of the current
study. In their study, exceedingly high shear was
induced by placing an external ring to the damaged
area, which produced a significant stenosis. In the
current study, flow was modulated within a lower
range of shear rate values. Furthermore, the stenosis
model is complicated by the development of turbu-
lence and regions of flow separation, whereas the
Fig. 4. Plasma PDGF-AB levels in the three experimental groups. PDGF-AB levels were
increased close to twofold in the LF group compared with baseline levels at 10 minutes and
then returned to baseline levels by 30 minutes. A similar trend was observed in the NF group,
but this trend was not statistically significant. In the HF group, PDGF-AB levels were not sig-
nificantly changed from baseline values.
Data are presented as mean ± SEM.
*p < 0.05 compared with baseline levels and the HF group at 10 minutes.
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flow profile in the rabbit CCA is close to being lam-
inar because of its uniform diameter and lack of side
branches. Kohler and Jawien36 used electron
microscopy to investigate the degree of platelet
adhesion in relation to flow at regions of arterial
injury in rats. No difference was found between the
LF and HF groups at 1 hour and 7 days after balloon
injury. These findings may be accounted for by the
narrow range of flow modulation (±30%), which
may minimally influence platelet adhesion, or by the
delayed time points selected for the study. Previous
investigation have demonstrated that platelet adhe-
sion to the balloon-injured rabbit aorta predomi-
nantly occurs during the first 30 minutes after
injury,37 the time course used in the current study.
We previously demonstrated that there are two
types of IH found in experimental anastomotic
regions: suture line IH, which represents vascular
healing, and arterial floor IH, which develops in
regions of flow oscillation and relatively low shear.19
Increasing flow by creating a distal arteriovenous fis-
tula markedly reduced anastomotic IH in experi-
mental end-to-side polytetrafluoroethylene anasto-
moses.21 Low shear stress also was found to promote
IH and cellular proliferation in vein and endothelial-
ized prosthetic grafts.38,39 Kraiss et al.39 demon-
strated that blood flow reduction is associated with
enhanced VSMC proliferation and PDGF-A expres-
sion. Because a putative shear stress-responsive ele-
ment (GAGACC) has been identified in the 5´-
flanking region of the PDGF-B gene,40 LF- and
shear-induced IH may therefore be related indirect-
ly to shear-mediated PDGF secretion from activated
platelets and VSMCs.
To determine whether cytokine release from acti-
vated platelets at regions of arterial injury is modu-
lated by flow, we assessed plasma PDGF-AB levels of
blood samples from the distal CCA. Plasma PDGF-
AB levels were significantly increased at 10 minutes
after injury and normalized by 30 minutes in the LF
group. Early release of PDGF-AB by LF may favor
intimal VSMC migration and proliferation. A recent
study by Caplice et al.41 demonstrated that PDGF-
AB released into coronary circulation after vascular
injury peaked at 5 minutes and returned to prean-
gioplasty levels by 30 minutes. Autologous serum
obtained from a patient’s coronary sinus after percu-
taneous transluminal coronary angioplasty promot-
ed proliferation of the patient’s VSMCs in culture.
This result implicated that early release of biologi-
cally active growth factors, even in small quantities,
may act locally in a synergistic fashion to produce a
significant mitogenic signal. Because platelets are
thought to be a major source of PDGF,42 the
observed peak in plasma PDGF-AB levels in the cur-
rent study is more than likely of platelet origin,
although some contribution from the underlying
injured VSMCs is possible. VSMCs are known to
secrete a variety of biologically active growth factors
(e.g., PDGF, basic fibroblast growth factor, epider-
mal growth factor) immediately after mechanical
injury.43 Further studies, including that of platelet
function and activity using specific monoclonal anti-
bodies for glycoprotein IIb/IIIa, a receptor block-
ade, will help elucidate the role of hemodynamic fac-
tors in cytokine release from the injured medial
smooth muscle cells. 
It is important to recognize the limitations
inherent to the experimental design of the current
study. A longer time course assessment and a more
direct quantitative evaluation of platelet adhesion
using radiolabeling techniques and scanning elec-
tron microscopy ideally would help further our
understanding of the role of hemodynamics in
platelet activation, aggregation, and adhesion in this
in vivo model.
CONCLUSIONS
We present experimental evidence that suggests
LF is conductive to platelet activation and the
release of mitogenic factors involved in the patho-
genesis of IH. Of interest is the positive effect of NF
or increased flow on this phenomenon. These find-
ings also support the concept that objective assess-
ment of flow parameters after vascular intervention
is critical in selecting patients in need for antithrom-
botic therapy and predicting interventions at risk for
failure for which there is a need for close hemody-
namic surveillance.
REFERENCES
1. Friedman RJ, Stemerman MB, Wenz B, Moore S, Gauldie J,
Gent M, et al. The effect of thrombocytopenia on experi-
mental arteriosclerotic lesion formation in rabbits: smooth
muscle cell proliferation and re-endothelialization. J Clin
Invest 1977;60:1191-1201.
2. Moore S, Friedman RJ, Singal DP, Gauldie J, Blasions MA,
Roberts RS. Inhibition of injury induced thromboatheroscle-
rotic lesions by antiplatelet serum in rabbits. Thromb
Haemost 1976;35:70-81.
3. Ip JH, Fuster V, Badimon L, Badimon J, Taubman MB,
Chesebro JH. Syndromes of accelerated atherosclerosis: role
of vascular injury and smooth muscle cell proliferation. J Am
Coll Cardiol 1990;15:1667-87.
4. Clowes AW, Clowes MM, Fingerle J, Reidy MA. Kinetics of
cellular proliferation after arterial injury. V. Role of acute dis-
tension in the induction of smooth muscle proliferation. Lab
Invest 1989;60:360-4.
5. Davies MG, Hagen PO. Pathobiology of intimal hyperplasia.
Br J Surg 1994;81:1254-69.
6. Majesky MW, Lindner V, Twardzik DR, Schwartz SM, Reidy
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 5 Bassiouny et al. 917
MA. Production of transforming growth factor b , during
repair of arterial injury. J Clin Invest 1991;88:904-10.
7. Ross R. The pathogenesis of atherosclerosis: an update. N
Engl J Med 1986;314:488-500.
8. Fingerle J, Johnson R, Clowes AW, Majesky MW, Reidy MA.
Role of platelets in smooth muscle cell proliferation and
migration after vascular injury in rat carotid artery. Proc Natl
Acad Sci USA 1989;86:8412-6.
9. Phillips DR, Charo IF, Parise LV, Fitzgerald LA. The platelet
membrane glycoprotein GPIIb-IIIa complex. Blood 1988;
71:831-43.
10. Kaplan AV, Leung LL, Leung WH, Drant GW, McDougall
IR, Fischell TA. Roles of thrombin and platelet membrane
glycoprotein IIb/IIIa in platelet-subendothelial deposition
after angioplasty in an ex vivo whole artery model. Circula-
tion 1991;84:1279-88.
11. Azrin MA, Ling FS, Cheng Q, Pawashe A, Migliaccio F,
Homer R, et al. Preparation, characterization, and evaluation
of a monoclonal antibody against the rabbit platelet glyco-
protein IIb/IIIa in an experimental angioplasty model. Circ
Res 1994;75:268-77. 
12. Mailhac A, Badimon JJ, Fallon JT, Fernandez-Ortiz A,
Meyer B, Chesebro JH, et al. Effect of an eccentric severe
stenosis on fibrinogen deposition on severely damaged vessel
wall in arterial thrombosis. Circulation 1994;90:988-96.
13. Strony J, Beaudoin A, Brands D, Adelman B. Analysis of
shear stress and hemodynamic factors in a model of coronary
artery stenosis and thrombosis. Am J Physiol 1993;265:
H1787-96.
14. Malek AM, Jackman R, Rosenberg RD, Izumo S. Endothe-
lial expression of thrombomodulin is reversibly regulated by
fluid shear stress. Circ Res 1994;74:852-60.
15. Frangos JA, Eskin SG, McIntire LV, Ives CL. Flow effects on
prostacyclin production by cultured human endothelial cells.
Science 1985;227:1477-9.
16. Bagyalakshmi A, Frangos J. Mechanism of shear-induced
prostacyclin production in endothelial cells. Biochem Bio-
phys Res Commun 1989;158:31-7.
17. Diamond SL, Eskin SG, McIntire LV. Fluid flow stimulates
tissue plasminogen activator secretion by cultured human
endothelial cells. Science 1989;243:1483-5.
18. Diamond SL, Sharefkin JB, Dieffenbach C, Frasier-Scott K,
McIntire LV, Eskin SG. Tissue plasminogen activator mes-
senger RNA levels increase in cultured human endothelial
cells exposed to laminar shear stress. J Cell Physiol
1990;143:364-71.
19. Bassiouny HS, White S, Glagov S, Choi E, Giddens DP,
Zarins CK. Anastomotic intimal hyperplasia: mechanical
injury or flow induced. J Vasc Surg 1992;15:708-17.
20. Zarins CK, Giddens DP, Bharadvaj BK, Sottiurai VS, Mabon
RF, Glagov S. Carotid bifurcation atherosclerosis: quantita-
tive correlation of plaque localization with flow velocity pro-
files and wall shear stress. Circ Res 1983;53:502-14.
21. Bassiouny SH, Krievins D, Zarins CK, Abu-Hamad G,
Glagov S. Distal arteriovenous fistula inhibits experimental
anastomotic intimal thickening. Surg Forum 1993;XLIV:
345-6.
22. Bassiouny HS, Song RH, Hong XF, Singh A, Glagov S.
Reduced flow enhances in vivo collagenase IV transcription
after arterial injury [abstract]. Circulation 1996;94 Suppl I:I-
349.
23. Langille BL, O’Donnell F. Reductions in arterial diameter
produced by chronic decreases in blood flow are endotheli-
um-dependent. Science 1986;231:405-7.
24. Pradelles P, Antoine C, Lellouche JP, Maclouf J. Enzyme
immunoassays for leukotrienes C4 and E4 using acetyl-
cholinesterase. Methods Enzymol 1990;187:82-9.
25. Eggesbo JB, Hjermann I, Joo GB, Ovstebo R, Kierulf P.
LPS-induced release of EGF, GM-CSF, GRO alpha, LIF,
MIP-1 alpha and PDGF-AB in PBMC from person with high
or low levels of HDL lipoprotein. Cytokine 1995;7:562-7.
26. Dernell WS, Wheaton LG, Gavin PR, Leathers CW, Leid RW.
Thromboxane as a measure of cutaneous vascular damage fol-
lowing irradiation. Plast Recons Surg 1994;93:1465-72.
27. Ruggeri ZM. Mechanisms of shear-induced platelet adhesion
and aggregation. Thromb Haemost 1993;70:119-23.
28. Ikeda Y, Handa M, Kawano K, Kamata T, Murata M, Araki
Y, et al. The role of von Willebrand factor and fibrinogen in
platelet aggregation under varying shear stress. J Clin Invest
1991;87:1234-40.
29. Chow TW, Hellums JD, Moake JL, Kroll MH. Shear stress-
induced Willebrand factor binding to platelet glycoprotein Ib
initiates calcium influx associated with aggregation. Blood
1992;80:113-20.
30. Mazeaud MM, Levenson J, Sang KHLQ, Simon A, Devynck
MA. Platelet aggregation and in vivo shear forces. Thromb
Haemost 1994;71:26-31.
31. Alshihabi SN, Chang YS, Frangos JA, Tarbell JM. Shear
stress-induced release of PGE2 and PGI2 by vascular smooth
muscle cells. Biochem Biophys Res Commun 1996;224:
808-14. 
32. Rubanyi GM, Vanhoutte PM. Oxygen-derived free radicals,
endothelium and responsiveness of vascular smooth muscle.
Am J Physiol 1986;250:H815-21.
33. Yan ZQ, Yokota T, Zhang W, Hansson GK. Expression of
inducible nitric oxide synthase inhibits platelet adhesion and
restores blood flow in the injured artery. Circ Res
1996;79:38-44.
34. Kamat SG, Michelson AD, Benoit SE, Moake JL, Rajasekhar
D, Heflums JD, et al. Fibrinolysis inhibits shear stress-induced
platelet aggregation. Circulation 1995;92:1399-1407.
35. Merino A, Cohen M, Badimon JJ, Fuster V, Badimon L. Syn-
ergistic action of severe wall injury and shear forces on
thrombus formation in arterial stenosis: definition of a
thrombotic shear rate threshold. J Am Coll Cardiol
1994;24:1091-4.
36. Kohler TR, Jawien A. Flow affects development of intimal
hyperplasia after arterial injury in rats. Arterioscler Thromb
1992;12:963-71.
37. Groves HM, Kinlough-Rathbone RL, Richardson M, Moore
S, Mustard JF. Platelet interaction with damaged rabbit
aorta. Lab Invest 1979;40:194-200.
38. Dobrin PB, Littooy FN, Endean ED. Mechanical factors pre-
disposing to intimal hyperplasia and medial thickening in
autogenous vein grafts. Surgery 1989;105:393-400.
39. Kraiss LW, Geary RL, Mattsson E Jr, Vergel S, Au YPT,
Clowes AW. Acute reductions in blood flow and shear stress
induce platelet-derived growth factor-A expression in baboon
prosthetic grafts. Circ Res 1996;79:45-52.
40. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF,
Gimbrone MA Jr. Platelet-derived growth factor B chain pro-
moter contains a cis-acting fluid shear-stress-responsive ele-
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cytic infiltration in the histopathologic specimens that
were examined at 1 week. However, an early inflammato-
ry reaction may have been present but not detected
because we did not use some specific labeling techniques
for lymphocytes or leukocytes. 
With regards to the question of anticoagulants in
patients who undergo infrainguinal prosthetic bypass
surgery, I think that the key findings of the study suggest
that measurement of the intraoperative and postoperative
hemodynamic parameters may help select those patients
who in fact may benefit from antithrombotic therapy. At
this time we are looking perspectively into the value of
impedance measurements, flow rates, and pressure gradi-
ents in vein grafts to assess the value of these parameters in
relation to immediate and long-term patency of infrain-
guinal vein grafts. To correlate these hemodynamic vari-
ables with the presence of intimal hyperplasia in vivo is dif-
ficult, however, we are hopeful that future imaging meth-
ods may help us understand and characterize this common
cause of restenosis more clearly.
I do not know the threshold flow velocity below
which intimal hyperplasia does occur. There is experi-
mental evidence that would suggest that if the shear val-
ues dropped to less than 5 dyne/cm2, intimal thickening
might in fact be enhanced. As we know, normal shear
stress values in the human arterial vessels range anywhere
from 10 to 20 dyne/cm2.
And finally, do I think that flow rate or shear rate is
the most important factor? This question is a complex
question. This is because of the direct effect of shear rate
on platelet activation. This effect is seen in high shear
stress values of 60 to 80 dyne/cm2. The direct effect of
hemodynamic shear on platelet activation is to be con-
trasted with the beneficial effect of or shear stress on pro-
duction of platelet antiaggregatory agents from the ves-
sel wall. High-flow conditions have been shown to
enhance tissue plasminogen activator from the endothe-
lial cells and smooth muscle cells. So, the net effect is
related to a dynamic equilibrium between the direct
effect of the shear forces on the platelet and on modula-
tion of the secretion of antiaggregatory agents from the
intima and media.
DISCUSSION
Dr. Thomas W. Wakefield (Ann Arbor, Mich.). In
this investigation, Dr. Bassiouny and colleagues have
shown the importance of flow rate on platelet activation
with an inverse correlation between flow rate and throm-
boxane B2 levels. In addition, a two-fold increase in
platelet-derived growth factor-AB early in the low-flow
group was not noted in the normal-flow or high-flow
groups. Intimal hyperplasia was only present in the low-
flow animals. The authors hypothesize that up regulation
and platelet activation in areas of low flow may be related
to increased platelet-exposure time to subendothelial col-
lagen. This study is an important elegant study that adds
much to our knowledge about arterial injury and the
response to that injury.
I have the following questions:
First, is there any information in your model on the
activation of other blood elements, such as leukocytes, in
the areas of low flow with prolonged resins times?
Second, as you suggested at the end of your presenta-
tion, some authors have made the recommendation for use
of oral anticoagulants in situations of low-flow velocities
after distal bypass graft procedures, especially those involv-
ing prosthetic grafts. Your data also would suggest that
antiplatelet agents should be incorporated into these treat-
ment regimens. Can you please comment on this concept?
Third, do changes in intimal hyperplasia occur at more
than or less than a threshold flow velocity, either in your
model or in patients? 
Additionally, could you tell us if the most important
factor here is flow rate or shear rate?
And finally, on the basis of your own experience and
review, is low shear or high shear most contributing to the
development of intimal hyperplasia?
Like all good investigative work, this study raises as
many new areas for further investigation as it answers. I
congratulate the authors on the excellent presentation and
thank them for sending me the manuscript. I also thank
the Midwestern Vascular Surgical Society for the opportu-
nity to discuss this paper.
Dr. Hisham S. Bassiouny. Thank you for these inter-
esting questions. I will try to answer them in order.
We did not find any evidence of lymphocytic or leuko-
42. Ostman A, Rall L, Hammacher A, Wormstead MA, Coit D,
Valenzuela P, et al. Synthesis and assembly of a functionally
active recombinant platelet-derived growth factor AB het-
erodimer. J Biol Chem 1988;263:16202-8.
43. Crowley ST, Ray CJ, Nawax D, Majack RA, Horwitz LD.
Multiple growth factors are released from mechanically
injured vascular smooth muscle cells. Am J Physiol 1995;
269:H1641-7.
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